GSE104737 Neo-Adjuvant Oncolytic Virotherapy Prior to Surgery Sensitizes Triple-Negative Breast Cancer to Immune Checkpoint Therapy

Contributors : M-C Bourgeois-Daigneault ; Adrian Pelin ; John C BellSeries Type : Expression profiling by arrayOrganism : Mus musculusTriple-negative breast cancer (TNBC) is an aggressive disease for which treatment options are limited and associated with severe toxicities.In this experiment we evaluated the response of 2 murine TNBC models to oncolytic Maraba virus infection.

http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE104737

Source: GEO: Gene Expression Omnibus - October 1, 2018 Category: Genetics & Stem Cells Tags: Expression profiling by array Mus musculus Source Type: research